|
Volumn 43, Issue 1, 2011, Pages 285-287
|
Significant improvement in patient survival after renal transplantation in the last decade
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AZATHIOPRINE;
CYCLOSPORIN;
MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PREDNISONE;
TACROLIMUS;
ADULT;
CADAVER DONOR;
CARDIOVASCULAR DISEASE;
CAUSE OF DEATH;
CONFERENCE PAPER;
FOLLOW UP;
GRAFT RECIPIENT;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY FAILURE;
KIDNEY TRANSPLANTATION;
LIVING DONOR;
MAJOR CLINICAL STUDY;
MORTALITY;
PRIORITY JOURNAL;
SEPSIS;
SURVIVAL;
TREATMENT OUTCOME;
FOLLOW-UP STUDIES;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
REOPERATION;
SURVIVAL RATE;
|
EID: 79951793462
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2010.09.105 Document Type: Conference Paper |
Times cited : (15)
|
References (7)
|